| Dr Theresa M Shin, OD | |
|
6455 Dobbin Rd, Columbia, MD 21045-5828 | |
| (443) 542-5999 | |
| (443) 542-5175 |
| Full Name | Dr Theresa M Shin |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 19 Years |
| Location | 6455 Dobbin Rd, Columbia, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053300616 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TA1959 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Catonsville Eye Group Inc | 2668512443 | 3 |
News Archive
ImmunoCellular Therapeutics, a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that the Company and Torrey Pines Institute for Molecular Studies in San Diego, CA have identified several peptides which can generate CD-133 specific T-cells. CD-133 is found in high abundance on cancer stem cells ("CSCs") which makes it promising for immunological targeting.
The Medical Research Council has announced the launch of a landmark study to identify the best dietary strategies to reduce heart disease and Type 2 diabetes.
Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing the way for him to undergo a minimally-invasive kidney removal. This allowed him to participate in a clinical trial using genetic material from his tumor to produce a vaccine to help fight his metastatic disease.
New York University has received a $2 million grant from the Mellon Foundation to expand its humanities faculty whose scholarship and teaching will focus on the past, present, and future of cities.
› Verified 1 days ago
| Provider Name | Catonsville Eye Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1578569190 PECOS PAC ID: 2668512443 Enrollment ID: O20091230000107 |
News Archive
ImmunoCellular Therapeutics, a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that the Company and Torrey Pines Institute for Molecular Studies in San Diego, CA have identified several peptides which can generate CD-133 specific T-cells. CD-133 is found in high abundance on cancer stem cells ("CSCs") which makes it promising for immunological targeting.
The Medical Research Council has announced the launch of a landmark study to identify the best dietary strategies to reduce heart disease and Type 2 diabetes.
Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing the way for him to undergo a minimally-invasive kidney removal. This allowed him to participate in a clinical trial using genetic material from his tumor to produce a vaccine to help fight his metastatic disease.
New York University has received a $2 million grant from the Mellon Foundation to expand its humanities faculty whose scholarship and teaching will focus on the past, present, and future of cities.
› Verified 1 days ago
| Provider Name | Annapolis Optometry, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1679717367 PECOS PAC ID: 7911183306 Enrollment ID: O20110519000519 |
News Archive
ImmunoCellular Therapeutics, a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that the Company and Torrey Pines Institute for Molecular Studies in San Diego, CA have identified several peptides which can generate CD-133 specific T-cells. CD-133 is found in high abundance on cancer stem cells ("CSCs") which makes it promising for immunological targeting.
The Medical Research Council has announced the launch of a landmark study to identify the best dietary strategies to reduce heart disease and Type 2 diabetes.
Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing the way for him to undergo a minimally-invasive kidney removal. This allowed him to participate in a clinical trial using genetic material from his tumor to produce a vaccine to help fight his metastatic disease.
New York University has received a $2 million grant from the Mellon Foundation to expand its humanities faculty whose scholarship and teaching will focus on the past, present, and future of cities.
› Verified 1 days ago
| Provider Name | Columbia Optometry Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1124305388 PECOS PAC ID: 1557519139 Enrollment ID: O20120925000082 |
News Archive
ImmunoCellular Therapeutics, a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that the Company and Torrey Pines Institute for Molecular Studies in San Diego, CA have identified several peptides which can generate CD-133 specific T-cells. CD-133 is found in high abundance on cancer stem cells ("CSCs") which makes it promising for immunological targeting.
The Medical Research Council has announced the launch of a landmark study to identify the best dietary strategies to reduce heart disease and Type 2 diabetes.
Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing the way for him to undergo a minimally-invasive kidney removal. This allowed him to participate in a clinical trial using genetic material from his tumor to produce a vaccine to help fight his metastatic disease.
New York University has received a $2 million grant from the Mellon Foundation to expand its humanities faculty whose scholarship and teaching will focus on the past, present, and future of cities.
› Verified 1 days ago
| Provider Name | Eldersburg Optometry, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1407906605 PECOS PAC ID: 6800041112 Enrollment ID: O20130312000156 |
News Archive
ImmunoCellular Therapeutics, a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that the Company and Torrey Pines Institute for Molecular Studies in San Diego, CA have identified several peptides which can generate CD-133 specific T-cells. CD-133 is found in high abundance on cancer stem cells ("CSCs") which makes it promising for immunological targeting.
The Medical Research Council has announced the launch of a landmark study to identify the best dietary strategies to reduce heart disease and Type 2 diabetes.
Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing the way for him to undergo a minimally-invasive kidney removal. This allowed him to participate in a clinical trial using genetic material from his tumor to produce a vaccine to help fight his metastatic disease.
New York University has received a $2 million grant from the Mellon Foundation to expand its humanities faculty whose scholarship and teaching will focus on the past, present, and future of cities.
› Verified 1 days ago
| Provider Name | Myeyedr Optometry Of Maryland Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609204437 PECOS PAC ID: 6002037629 Enrollment ID: O20141024000821 |
News Archive
ImmunoCellular Therapeutics, a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that the Company and Torrey Pines Institute for Molecular Studies in San Diego, CA have identified several peptides which can generate CD-133 specific T-cells. CD-133 is found in high abundance on cancer stem cells ("CSCs") which makes it promising for immunological targeting.
The Medical Research Council has announced the launch of a landmark study to identify the best dietary strategies to reduce heart disease and Type 2 diabetes.
Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing the way for him to undergo a minimally-invasive kidney removal. This allowed him to participate in a clinical trial using genetic material from his tumor to produce a vaccine to help fight his metastatic disease.
New York University has received a $2 million grant from the Mellon Foundation to expand its humanities faculty whose scholarship and teaching will focus on the past, present, and future of cities.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Theresa M Shin, OD 1950 Old Gallows Rd Ste 520, Vienna, VA 22182-3970 Ph: (703) 847-8899 | Dr Theresa M Shin, OD 6455 Dobbin Rd, Columbia, MD 21045-5828 Ph: (443) 542-5999 |
News Archive
ImmunoCellular Therapeutics, a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that the Company and Torrey Pines Institute for Molecular Studies in San Diego, CA have identified several peptides which can generate CD-133 specific T-cells. CD-133 is found in high abundance on cancer stem cells ("CSCs") which makes it promising for immunological targeting.
The Medical Research Council has announced the launch of a landmark study to identify the best dietary strategies to reduce heart disease and Type 2 diabetes.
Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing the way for him to undergo a minimally-invasive kidney removal. This allowed him to participate in a clinical trial using genetic material from his tumor to produce a vaccine to help fight his metastatic disease.
New York University has received a $2 million grant from the Mellon Foundation to expand its humanities faculty whose scholarship and teaching will focus on the past, present, and future of cities.
› Verified 1 days ago
Eye Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10801 Hickory Ridge Rd Ste 200, Columbia, MD 21044 Phone: 410-997-1800 Fax: 301-596-5070 | |
Jeffrey L. Morer, Od, Pc Optometrist Medicare: Medicare Enrolled Practice Location: 6700 Alexander Bell Dr, Suite 200, Columbia, MD 21046 Phone: 888-964-6681 Fax: 888-662-0859 | |
Dr. Michael Kotlicky, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 8827 Columbia 100 Pkwy Ste 3, The Signature Centre, Columbia, MD 21045 Phone: 410-730-5808 Fax: 410-730-5893 | |
Tuleen Alam, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6250 Columbia Crossing Dr, Suite K, Columbia, MD 21045 Phone: 443-285-0100 Fax: 443-285-0110 | |
Dr K Eyecare Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 8765 Centre Park Dr Ste 13, Columbia, MD 21045 Phone: 443-631-4461 | |
Dr. Carl S Kukielka, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10025 Governor Warfield Pkwy, Suite 103, Columbia, MD 21044 Phone: 410-772-5412 Fax: 410-828-2018 |